Similar articles

• Comments on the MRC/BHF Heart Protection Study.

  Sirtori CR. Sirtori CR. Lancet. 2003 Aug 30;362(9385):744; author reply 744-5. doi: 10.1016/S0140-6736(03)14213-4. Lancet. 2003. PMID: 12957102 No abstract available.
• Comments on the MRC/BHF Heart Protection Study.

  Mikhail N. Mikhail N. Lancet. 2003 Aug 30;362(9385):744; author reply 744-5. doi: 10.1016/S0140-6736(03)14212-2. Lancet. 2003. PMID: 12957101 No abstract available.
• [Statin treatment in type 2 diabetes. Is it a must today?].

  Faust M. Faust M. MMW Fortschr Med. 2003 Feb 27;145(9):35-6. MMW Fortschr Med. 2003. PMID: 12666527 German. No abstract available.
• [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].

  Tomiyama H, Doba N. Tomiyama H, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:393-7. Nihon Rinsho. 2001. PMID: 11347101 Review. Japanese. No abstract available.
• Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.

  Ito MK, Talbert RL, Tsimikas S. Ito MK, et al. Pharmacotherapy. 2006 Jul;26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. doi: 10.1592/phco.26.7part2.85S. Pharmacotherapy. 2006. PMID: 16803418 Review.